Extrafollicular CD19lowCXCR5−CD11c− double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosus
Open Access
- 9 October 2024
- journal article
- research article
- Published by Elsevier in Journal of Translational Autoimmunity
- Vol. 9, 100252
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Xist ribonucleoproteins promote female sex-biased autoimmunityCell, 2024
- Extrafollicular IgD−CD27−CXCR5−CD11c− DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19Cell Reports, 2023
- IgD−CD27− double negative (DN) B cells: Origins and functions in health and diseaseImmunology Letters, 2023
- Plasmablast‐like Phenotype Among Antigen‐Experienced CXCR5–CD19low B Cells in Systemic Lupus ErythematosusArthritis & Rheumatology, 2022
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus ErythematosusArthritis & Rheumatology, 2019
- Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus ErythematosusImmunity, 2018
- Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95Arthritis & Rheumatism, 2008
- Control of Toll-like Receptor 7 Expression Is Essential to Restrict Autoimmunity and Dendritic Cell ProliferationImmunity, 2007
- Similar CD19 Dysregulation in Two Autoantibody-Associated Autoimmune Diseases Suggests a Shared Mechanism of B-Cell Tolerance LossJournal of Clinical Immunology, 2006
- The effect of anti‐CD40 ligand antibody on B cells in human systemic lupus erythematosusArthritis & Rheumatism, 2002